A Look Inside the Chart, Technical Insights - Research on Trupanion, Tobira Therapeutics, Old Second Bancorp and Heska

NEW YORK, NY / ACCESSWIRE / December 7, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Trupanion Inc. (TRUP), Tobira Therapeutics Inc. (TBRA), Old Second Bancorp Inc. (OSBC) and Heska Corp. (HSKA). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

TRUP Research Package: http://www.traders-choice.com/pdf?s=TRUP

TBRA Research Package: http://www.traders-choice.com/pdf?s=TBRA

OSBC Research Package: http://www.traders-choice.com/pdf?s=OSBC

HSKA Research Package: http://www.traders-choice.com/pdf?s=HSKA

============

Highlights from today's reports include:

On Friday, December 4, 2015, the NASDAQ Composite ended at 5,142.27, up 2.08%, the Dow Jones Industrial Average advanced 2.12%, to finish the day at 17,847.63, and the S&P 500 closed at 2,091.69, up 2.05%.

- Trupanion Inc.'s stock added 2.13% to close Friday's session at USD 8.63. The company's shares oscillated between USD 8.24 and USD 8.71. The stock recorded a trading volume of 0.04 million shares, which was below its 50-day daily average volume of 0.09 million shares. Over the last one week Trupanion Inc.'s shares have advanced 6.81% and in the past one month the stock has gained a momentum of 23.82%. In addition, over the last three months the stock has gained 20.03% and year to date the shares have picked up 24.53%. The stock has returned 7.74% in the past six months, on a compounded total return basis. Further, the stock is trading at a price to book (mrq) ratio of 5.04 and a price to sales (ttm) ratio of 1.72. Moreover, the stock is trading above its 50-day and 200-day moving averages of USD 7.46 and USD 7.84, respectively. Trupanion Inc. has market capitalization of USD 244.06 million.

- Tobira Therapeutics Inc.'s stock declined 4.26% to close Friday's session at USD 11.47. The share price vacillated between USD 11.10 and USD 11.97. The stock recorded a trading volume of 0.03 million shares, which was below its 50-day daily average volume of 0.05 million shares. Over the last three days Tobira Therapeutics Inc.'s shares have declined by 15.35% but in the past one month the stock has moved up 12.78%. However, in the last six months the stock has lost 35.71% while year to date the shares have picked up 39.57%. Further, the company is trading at a price to book (mrq) ratio of 4.39. Moreover, the stock is trading above its 50-day moving average of USD 10.71 but below its 200-day moving average of USD 13.62. Tobira Therapeutics Inc. has a market capitalization of USD 215.75 million and enterprise value of USD 162.19 million.